NeoImmuneTech, Inc. is a clinical-stage biopharmaceutical company. which engages in the development of T cell-centered novel immunotherapeutics. The firm develops its product NT-I7 for the treatment of lymphopenia. The company was founded by Se Hwan Yang in January 2014 and is headquartered in Rockville, MD.